                                  ORIGINAL
         3Jn tbe Wniteb ~tates (!Court of jfeberal (!Claims
                              OFFICE OF SPECIAL MASTERS
                                           No. 15-535V             REISSUED FOR PUBLICATION
                                      Filed: Januaiy 3, 2017                     13 FEB 2017
                                          PUBLISHED                                 OSM
                                                                       U.S. COURT OF FEDERAK CLAIMS
    * * * * *           * * *   * * * * *
    VERNON D. BEGLEY,                   *
                                        *            Dismissal; Motion to Dismiss; Polio; Post-
                Petitioner,             *            Polio Syndrome; Vaccine Administered
                                        *            Before the Enactment of the Vaccine
    v.                                        *      Program; Prisoner; Equitable Tolling
                                *
    SECRETARY OF HEALTH         *
    AND HUMAN SERVICES,         *
                                *                                               FILED
              Respondent        *                                              JAN '-3 2017
                                *                                                    OSM
    * * * * * * * * * * * * * * *                                                U.S. COURT OF
                                                                               FEDERAL CLAIMS
Vernon D. Begley, Florida City, FL, pro se.
Jennifer Reynaud, Esq., US. Department ofJustice, Washington, DC, for respondent.
                                   DISMISSAL DECISION1
Roth, Special Master:

        This matter is before the undersigned on respondent's Motion to Dismiss, filed August 28,
2016. Vernon Begley ("Mr. Begley" or "petitioner"), an inmate of the Florida Department of
Corrections, filed this petition on May 27, 2015, seeking compensation for an alleged vaccine-
related onset of poliomyelitis ("polio") under the National Vaccine Injury Compensation Program
("the Program"). 2 42 U.S.C. § 300aa- 10-3.4. Respondent moved to dismiss the petition, arguing


1
  Because this published decision contains a reas.o ned explanation for the action in this case, I
intend to post this decision on the United States Court of Federal Claims' website, in accordance
with the E-Govemment Act of2002, Pub. L. No. 107-347, § 205, 116 Stat. 2899, 2913 (codified
as amended at 44 U.S.C. § 3501 note (2012)). In accordance with Vaccine Rule 18(b), petitioner
have 14 days to identify and move to delete medical or other information, that satisfies the
criteria in§ 300aa-12(d)(4)(B). Fmther, consistent with the rnle requirement, a motion for
redaction must include a proposed redacted decision. If, upon review, I agree that the identified
material fits within the requirements of that provision, I will delete such material from public
access.

2
 The Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L.
No. 99-660, 100 Stat. 3755, codified as amended, 42 U.S.C. §§ 300aa-10 et seq. (hereinafter
                                                                                                  1
 that it is time-batTed pursuant to§ 16(a)(l). Petitioner argues that dismissal of this petition would
 be an injustice and, because of his unique and extraordinat"y circumstances, the statute of
 limitations should be equitably tolled. Based on the established case law, petitioner's claim is
 time-barred. Respondent's motion for dismissal is therefore GRANTED.
                                      I.      Procedural History
          On May 27, 2015, Mr. Begley, proceeding prose, filed a petition seeking compensation
  for injuries suffered as a result of a polio vaccine he received as a child in the late 1950s. Mr.
  Begley's case was originally assigned to Special Master Dorsey. 3 After a status conference with
  Mr. Begley and respondent's counsel, Special Master Dorsey issued an Order stating that if Mr.
  Begley did not obtain the assistance of an attorney by December 5, 2015, his case would proceed
  as prose. Order, filed 10/9/15, ECF No. 8. On October 13, 2015, Mr. Begley filed a letter he had
. written stating that he had been recently diagnosed with multiple-sclerosis "brain damage," and
  vision problems. Letter, filed Oct. 13, 2015, ECF No. 9.
         The case was then reassigned to me on October 19, 2015. Notice of Reassignment, ECF
 No. 11. In order to assist Mr. Begley, I issued an Order on December 18, 2015, requiring him to
 submit a status report by February 1, 2016 with the names and mailing addresses of any medical
 providers from which he would like to obtain his medical records. My Order included instructions
 for issuing subpoenas for medical records. A telephonic status conference was scheduled for
 Wednesday, April 13, 2016. Order, issued December 18, 2015, ECFNo. 16.
         On February 17, 2016, Mr. Begley filed a motion requesting that the cmut appoint an
 attorney to represent him. He attached a list of facilities he wished to subpoena. ECF No. 13. The
 handwritten list is difficult to read, but includes facilities that would not appear to have his medical
 records from the 1950s (such as the Clark County and Indiana State Departments of Health) and
 organizations entirely umelated to his claim (such as National Public Radio, the Florida
 Department of Corrections, and two organizations that Mr. Begley appears to believe might be in
 possession of scientific papers related to polio). 4 In an effort to be diligent, my Chambers



 "Vaccine Act" or "the Act"). Hereafter, for ease of reference, individual section references will
 be to 42 U.S.C. § 300aa of the Act.
 3   Special Master Dorsey was elevated to Chief Special Master on September 1, 2015.
 4
   During status conferences, petitioner has referenced other litigation that is cunently pending. It
 appears that several of the institutions included in this list (such as the Florida Department of
 Corrections) may be involved in other cases that he has filed. It also appears that he might not
 fully understand what a subpoena is. In an attachment to his motion for the court to appoint
 counsel on his behalf, petitioner wrote, "I must subpoena the Fla. Depattment of Corrections to
 do the spinal tap and send it t (sic) a polio lab to prove "tame polio" vs. wild virus. D.O.C. so far
 refuses to do any test." Attachment to Motion for Appointment of Counsel, ECF. No. 13 at 2.
 Petitioner's unfamiliarity with the legal system led to the multiple oppmtunities I provided him
 to find counsel familiar with the Program to communicate with petitioner. Ultimately none of
                                                                                                       2
attempted to contact several of the facilities listed to determine how long they keep their records
before destroying them. The phone line for one has been disconnected. Another has only been
open since 1994, so it would have been impossible for Mr. Begley to have ever been a patient
there. In any event, from the investigation it appears that the medical facilities listed would not
have retained medical records for so many decades, and that the remainder of the requests were
outside the scope of this litigation. On March 15, 2016, I issued an Order explaining that a special
master does not have the authority to appoint an attorney for any petitioner, and again provided
the list of attorneys admitted to the bar of the United States Court of Federal Claims who might be
able to assist him. Order, issued March 15, 2016, ECF No. 15.
        A status conference was held on April 13, 2016. Petitioner's unsuccessful attempts to
retain counsel were discussed, and petitioner was again encouraged to continue reaching out to
attorneys in the Program in an effmi to speak with an attorney. Petitioner was again provided with
the names and contact information for the vaccine law clinics as well as members of the bar.
       Mr. Begley then filed a status report on May 16, 2016, stating that he was unable to obtain
counsel, despite contacting the various attorneys suggested by the colU't. 5 Status Repmi, filed May
16, 2016, ECFNo. 19.
        Another status conference was held on August 24, 2016. Petitioner explained that despite
efforts he was unable to retain counsel. The deficiencies in his case were discussed. Respondent's
counsel was ordered to file a motion to dismiss, which would then enable petitioner to submit all
of his arguments in support of his petition in a response to the court. Order, issued August 25,
2016, ECF No. 22.
       Respondent filed her Motion to Dismiss ("Motion") on August 29, 2016, arguing that Mr.
Begley's petition was not filed within the statutorily prescribed limitations period set forth in §
16(a)(l) and therefore must be dismissed. Mr. Begley filed his response to respondent's Motion
on September 15, 2016, arguing that dismissal of his petition would be m\just and that the statutory
deadline must be equitably tolled considering his circumstances. Response to Motion
("Response"), filed Sept. 15, 2016, ECFNo. 25.
       This matter is now ripe for decision.
                                        II.     Background
        Petitioner believes that he received a polio vaccination in 1958, but is not sure of the date.
Petitioner, who has been incarcerated for the past 32 years, states that the onset of his polio was




the facilities that petitioner listed were determined to be able to provide documents that would
support the factual basis for his claim.
5
 Petitioner provided a list of the attorneys he contacted from the bar membership provided to
him. However, none of the attorneys contacted would speak with him.


                                                                                                     3
after he received this vaccination. 6 I-le then began experiencing symptoms of post-polio syndrome
in 1988. 7 Petitioner's Exhibit ("Pet. Ex.") I at 5. Petitioner alleges that the polio vaccination
caused him to develop polio and post-polio syndrome. Because petitioner received this
vaccination prior to the effective date of the Program, October I, 1988, petitioner's polio, which
he claims he developed immediately after receiving the polio vaccine, is subject to the Program's
filing requirements applicable to pre-Program vaccinations, which are laid out in § 16(a)(l).
Likewise, his claim of post-polio syndrome, which he asserts occurred "around 1988," is subject
to the same filing requirements because petitioner states that this injury was caused by the same
pre-Act vaccination which allegedly caused his polio. Despite the supposed date of his injury or
aggravation thereof, petitioner did not file a claim for compensation until 2015, some 57 years
after receiving the allegedly causal vaccine and approximately 27 years after experiencing post-
polio syndrome.
                                         III.    Discussion
        In her Motion to Dismiss, respondent states that petitioner failed to file his claim within
the statutorily prescribed 28 months after the October I, 1988 date set forth in§ 16(a)(l), and
therefore, petitioner's claim is time-barred. Respondent also argues that § 16(a)(l) further
prohibits this claim because petitioner filed his claim more than 36 months after experiencing
symptoms of his alleged significant aggravation. According to respondent, this claim must be
dismissed as it "is insufficient to result in a finding of entitlement to compensation, even if all of
petitioner's allegations are accepted as true." Respondent's Motion to Dismiss ("Motion") at I.
Respondent cites to several cases which have held that § 16(a)(l) is a statute of repose, and
therefore not subject to the doctrine of equitable tolling. See Goodlock v. Sec'y of Health and
Human Servs., No. 05-1240V, 2006 WL 5630235 (Fed. Cl. Spec. Mstr. Jan. 9, 2006); see also
Stankovic v. Sec '.Y of Health and Human Servs., No. 15-424V, 2015 WL 5656344 (Fed. Cl. Spec.
Mstr. Sept. 2015).



6
 Oral polio vaccine (OPV) is an attenuated viral vaccine. On rare occasions, if a person is
seriously under-immunized, an excreted vaccine-virus can continue to circulate for an extended
period of time. In very rare instances, the vaccine-virus can genetically change into a form that
can paralyze. This is referred to as a circulating vaccine-derived poliovirus (cVDPV). World
Health Organization, "What is vaccine-derived polio?" http://www.who.int/features/ga/64/en/,
updated October 2015 (last visited Nov. 29, 2016). Paralytic polio following receipt ofOPV is a
Table injury. § 14(a)(III)(a).
7
  Post-polio syndrome is a condition that affects polio survivors years after recovery from an
initial acute attack of the polio virus. Most common symptoms include slowly progressive
muscle weakness, fatigue (both generalized and muscular), and a gradual decrease in the size of
muscles (muscle atrophy). Pain from joint degeneration and increasing skeletal deformities may
precede the weakness and muscle atrophy. National Institute of Neurological Disorders and
Strokes, "Post-Polio Syndrome Fact Sheet," last modified February 23, 2015,
http://www.ninds.nih.gov/disorders/post polio/detail post polio.htm (last visited Nov. 29,
2016).
                                                                                                    4
         Petitioner believes that his claim is not time-barred and argues that his status as an inmate
justifies tolling the statute of limitations. Petitioner contends that the controlled environment of
the prison system frustrates his access to the courts and the information required to organize facts
and evidence in order to comply with the requirements of the Program. See Response to Motion
to Dismiss, ECF No. 25.

        § 16(a)(l) addresses the issue of limitations of actions for petitions involving vaccines
which were administered prior to the effective date of the Program, October 1, 1988. The statute
states:
In the case of -

        (1) A vaccine set forth in the Vaccine Injury table which is administered before October 1,
        1988, if a vaccine-related injury or death occurred as a result of the administration of such
        vaccine, no petition may be filed for compensation under the Program for such injury or
        death after the expiration of28 months after October 1, 1988, and no such petition may be
        filed if the first symptom or manifestation of onset or of the significant aggravation of such
        injury occurred more than 36 months after the date of administration of the vaccine.
42 U.S.C. § 300aa-16(a)(l). Petitions involving vaccines that were administered after October 1,
1988, are governed by § 16(a)(2). Because petitioner allegedly received the allegedly causal
vaccination in the 1950s, his claim is subject to the provisions contained in§ l 6(a)(l).
A. Time Limits for Petitioner's Causation Claim

          In consideration of the patties' arguments, there are three fundamental questions before the
comi. First, given that petitioner received the allegedly causal vaccination approximately thirty
years before the Progra111's enactment, when would he have had to have filed his claim in order
for it to be timely? Second, given that petitioner allegedly began experiencing a subsequent injury
that stems from his initial injury, i.e., post-polio syndrome, does this change the determination
about whether this is a pre-Act case? Third, does his incarceration excuse a filing well past the
deadlines established in the Act?
         Because petitioner has not been able to file any medical records, the only timeline of events
available is that provided by Mr. Begley himself. Based on his memory, petitioner claims that his
initial onset of polio was in or around 1958 and that he subsequently began experiencing symptoms
of post-polio syndrome in 1988. He claims that both ailments were a result of the polio vaccination
he received sometime in the late 1950s. Response, ECF No. 25.
       Relying upon the dates provided by petitioner, I find that the vaccine in question was
administered approximately 30 years prior to the Vaccine Progra111's effective date on October 1,
1988. Therefore, for a pre-Act vaccination to be timely, according to§ 16(a)(l), petitioner's claims
needed to have been filed within the 28-month deadline following October 1, 1988, or prior to
February 1, 1991. Here, petitioner filed his claim on May 27, 2015, more than 24 years after the
deadline. His claim is therefore time-bai-red by§ 16(a)(l).



                                                                                                    5
B. Time Limitations for Petitioner's Significant Aggravation Claim

        According to petitioner, the first manifestation of onset of his post-polio syndrome
occurred in 1988. In addition to the 28-month deadline for the filing of pre-Act cases,§ 16(a)(I)
also states that "no petition may be filed if the first symptom or manifestation of onset or of the
significant aggravation of such injury occun-ed more than 36 months after the date of
administration of the vaccine" (emphasis added). Some 30 years elapsed between petitioner's
receipt of the allegedly causal vaccination and the onset of his post-polio syndrome. That length
of time means that petitioner cannot prevail on a significant aggravation claim.
        I have made no determination as to the onset of petitioner's post-polio syndrome.
Petitioner has provided little detail about the onset of his alleged significant aggravation, just
dating it to 1988. Ultimately, whether petitioner experienced an onset of post-polio syndrome in
January 1988 (pre-Act) or December 1988 (post-Act) makes no difference in terms of statutory
requirements for timeliness, as § 16(a)(I) governs all cases involving vaccines "administered
before October 1, 1988" (emphasis added).
C. Availability of Equitable Tolling

         Petitioner argues that his unique circumstances warrant equitable tolling. He has been in
prison for the past 32 years, and he states that he was unaware of the Program and thus unable to
file a timely petition. 8 Thus, petitioner argues that his claim should be equitably tolled considering
the "unique surrounding circumstances" of his imprisonment. While Cloer v. Secretary ofHealth
and Human Services has established that equitable tolling can apply to post-Act vaccination
claims, the Federal Circuit clarified that tolling is only available to post-Act vaccination claims in
which "some extraordinary circumstance stood in [petitioner's] way." 654 F.3d 1322, 1344
(quoting Pace v. DiGuglielmo, 544 U.S. 408, 418 (2005)). This equitable relief has been granted
only sparingly in federal courts. See Irwin v. Dep 't of Veterans Affairs, 498 U.S. 89, 96 (1990).
Moreover, previous case law has established that§ 16(a)(l) is a statute of repose, and therefore,
equitable tolling is not applicable for pre-Act claims, regardless of the unique circumstances in
question. See Lampfv. Gilbertson, 50 I U.S. 350 (1991 ); Lombardo v. Sec'y ofHealth and Human
Servs., 34 Fed.Cl. 21 (1995).
        The Vaccine Program was enacted to provide relief to individuals whose injuries or death
qualified them or their estate for compensation under the terms of the Program. Wiley v. United
States, 68 Fed. Cl. 733, 736 (2006). However, the financial appropriation could not possibly be
large enough to ensure that all potential retrospective victims whose injuries had occurred prior to
the enactment of the Vaccine Program could be compensated. Id. Therefore, Congress specified
a cutoff date. Any claim based upon a vaccination that occurred before the Program's enactment

8
  Petitioner's ability to file his Petition in this matter indicates that he had the ability to exercise
his legal rights. His incarceration did not ultimately prevent him from filing this case. His
argument, then, is that he did not learn of the Program in time to file a timely Petition. Failure to
learn of the Program in order to file a timely Petition has not been found to constitute grounds for
tolling the statute of limitations. Lombardo, 34 Fed. Cl. at 28 (quoting S. 2117, 98th Cong., 1st
Sess. § 2115(b) (1983)).
                                                                                                       6
date (October 1, 1988) had to be filed within 28 months of the enactment date, i.e., before February
I, 1991. With this understanding, the United States Court of Appeals for the Federal Circuit has
ruled that § 16(a) is a statute ofrepose. See Brice v. Sec'y of Health and Human Servs., 240 F.3d
1367, 1371 (Fed. Cir. 2001). 9
        A statute of repose is distinguishable from a statute of limitations in that a statute of repose
runs from a determined date unrelated to the injury and does not consider the date of injury as a
factor when determining the deadline for filed claims. Wiley, 69 Fed. Cl. at 736; Lombardo, 34
Fed. CL 21, 26; see also Lamp/, 501 U.S. at 363. As opposed to a statute of limitations, for which
the main purpose is "the prevention of stale claims, a statute of repose is designed to provide
immunity to the defendant and 'relieve potential defendants from anxiety over liability for acts
committed long ago."' Wiley, 69 Fed. Cl. at 373 (quoting Massard v. Sec'y a/Health and Human
Servs., 25 Cl.Ct. at 421, 425 (1992)).
        In Wiley, the couti looked to Lombardo v. Secretary of Health and Human Services'
analysis of the various factors used to conclude that§ 16(a)(l) of the Vaccine Act was a statute of
repose. 69 Fed.Cl. at 737. Both courts stated that the most significant factor was the plain language
of§ 16(a)(l), which provides valuable insight into the deadline's classification and "suggests that
Congress sought to extend relief to those vaccinated before the Act went into effect, but also
wanted to provide the government with a definite date after which it would no longer have to
defend against any such retroactive suits." Id (quoting Lombardo, 34 Fed. Cl. at 27). Specifically,
the statute states that "no petition may be filed" after the deadline. Additionally, there is no
provision in the Vaccine Act that suggests tolling of the statutory filing deadlines. Although the
Supreme Couti has held that the binding character of the language is only marginally probative of
congressional intent, this unambiguous language leans toward a finding that § l 6(a)(l) is a statute
of repose.
        The time period provided in § 16(a)(l) did not run with accrual of a specific claim, but
rather began to run with the effective date of the Program. Both coutis found that this independent
stmi date of the statutory time limit in§ 16(a)(l) further establishes that Congress intended this
deadline to serve as a statute of repose. Wiley, 69 Fed. Cl. at 737; Lombardo, 34 Fed. Cl at 27.
       Congress was keenly aware that some meritorious claims might not be filed before the
deadline established in the Act. Congress initially provided a filing period of 24 months for
outstanding claims in§ 16(a)(l). After it became clear that the Secretmy of Health and Human
Services was not advertising the Program as Congress had anticipated, this period was later
extended to 28 months. 136 Cong. Rec. SIS, 198-99 (daily ed., Oct. 12, 1990) (remarks of Sen.

9 In Cloer, the Couti of Appeals for the Federal Circuit overruled Brice insofar as the Brice court
"precluded application of the doctrine of equitable tolling in Vaccine Act cases." Cloer v. Sec'y
of Health Human Servs., 654 F.3d 1322, 1325 (Fed. Cir. 2011). As Cloer dealt with a post-Act
case, Brice's discussion of pre-Act cases remains valid. Given Brice, Cloer, and their progeny,
equitable tolling is available for post-Act cases only in very rare circutnstances; it is not available
at all for cases involving pre-Act vaccinations.

                                                                                                      7
Kennedy). Congress feared that individuals who had only just heard of or had not yet heard of the
Program would not have sufficient time to collect the necessary materials to file a petition for
compensation. Id. To address this issue, Congress added four months to the deadline date
(February 1, 1991) in order to file a claim in pre-Act cases. Congress was thus aware of the
problem identified by petitioner in the instant case and chose to address it. Unfortunately for
petitioner, their amendment to the deadline was not generous enough to encompass his claim, filed
approximately 26 years too late.
         Finally, the legislative history of § 16(a)(l) reinforces the conclusion that Congress
intended the provision to be a statute of repose. When introduced in the Senate, the Vaccine Act
contained a statute of limitations provision which allowed a petition to be filed after the statutory
deadline "if the petitioner demonstrates that he or she was not informed [of the vaccine
compensation program], or did not know that the injury was compensable." Lombardo, 34 Fed.
Cl. at 28 (quoting S. 2117, 98th Cong., !st Sess. § 2115(b) (1983)). However, when the Vaccine
Act was finally enacted by Congress, it did not contain this provision, nor did it permit the filing
of petitions after the deadline. § 16(a)(l). Congress was aware of how "to expressly provide for
the filing of untimely petitions for compensation when a petitioner was unaware that his injury
was compensable, but chose not to do so in the eventual enactment." Id This history indicates
that Congress had no intention of allowing petitions based on pre-Act vaccinations to be filed after
the February I, 1991 deadline and, therefore, did not want§ 16(a)(l) to be equitably tolled. All
of these factors demonstrate clear congressional intent to make § 16(a)(l) a statute of repose.
Wiley, 69 Fed.Cl. at 737; Lombardo, 34 Fed.Cl. at 27; see also Brice., 240 F.3d at 1371. Because
the statutory time deadline in question is a statute of repose, petitioner's claim is not subject to
equitable tolling.
         Even if§ 16(a)(l) did not entirely preclude the possibility of equitable tolling in pre-Act
cases, petitioner would still be unable to avail himself of that remedy to excuse his untimely filing.
While Cloer does allow equitable tolling in post-Act cases, the remedy is only available in
"extraordinary circumstances." Cloer, 654 F.3d at 1344-1345. Judges and special masters have
applied Cloer strictly, only rarely finding that a petitioner's circumstances are unique enough to
warrant equitable tolling. See Mojica v. Sec'y of Health and Human Servs., 102 Fed. Cl. 96, 101
(2011 ). Recently, this issue was addressed in the context of mental incapacity. The petitioner in
Hodge had a lengthy history of mental illness and was noted by several treaters to have been
impaired. Petitioner's mental incapacity was found to have been an extraordinary circumstance
that ultimately excused his untimely filing. Hodge v. Sec'y of Health and Human Servs., No. 09-
453V, 2015 WL 9685916 (Fed. Cl. Dec. 21, 2015). However, Hodge should not be interpreted to
allow indefinite tolling of the statute oflimitations. After discussing Hodge and other cases dealing
with mental capacity, another special master ruled that in order for mental incapacity to warrant
equitable tolling, the petition's untimeliness must be the "direct result" of that incapacity. Gray v.
Sec'y of Health and Human Servs., No. 15-146V, 2016 WL 787166, at *6 (Fed. Cl. Feb. 4, 2016).

       In the instant case, petitioner argues that his circumstances are unique in that his
imprisonment prevented the timely filing of his petition. This issue has already been addressed.
In Wiley, 69 Fed. Cl. 733 (2006), the petitioner, a prison inmate, filed his pre-Program vaccination

                                                                                                    8
claim foUiteen years after the statutory deadline. Id. at 735. Though harsh, the cou1t found that
the petitioner's ability to timely file his claim was not affected by the circumstances of his
incarceration, and even if it were, these circumstances were not so extreme as to justify equitable
tolling. Id. at 737. The court concluded that "even if [petitioner] had shown due diligence, the
Special Master's conclusion is coITect that§ 16(a)(l) is a statute ofrepose, making equitable tolling
inapplicable." Id. Mr. Begley's claim closely parallels the Wiley case. Here, as in Wiley, petitioner
received a vaccine subject to the pre-Act requirements of§ 16(a)(l). Here, as in Wiley, petitioner
did not file his claim until years after the statutory deadline had expired. And here, as in Wiley,
petitioner's unique circumstance of being incarcerated does not warrant applying equitable tolling
to his claim.

                                        IV.     Conclusion
        Succinctly stated, petitioner's claim is time-barred because he filed approximately 24 years
after the statutory deadline for filing retrospective claims pursuant to the Vaccine Act. § 16(a)(l)
is a statute of repose and not a statute of limitations and is not subject to equitable tolling.
Therefore, the coUit has no choice but to grant respondent's motion to dismiss the claim as
untimely filed.

       Respondent's motion to dismiss is hereby GRANTE          The petition is therefore dismissed.
The clerk shall enter judgment accordingly.
               IT IS SO ORDERED.




                                                                                                   9
